Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Challenges with implementing CAR-T approaches in solid tumors

Yufei Wang • 11 Apr 2022
AACR 2022
General CAR-T

Yufei Wang, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses challenges associated with implementing CAR T-cell approaches in solid tumors. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

More from Yufei Wang

0:49
CAR-T cell approaches to combat an immunosuppressive tumor microenvironment
Yufei Wang • 11 Apr 2022
1:14
Anti-CAIX immune restoring CAR T-cells reverse immunosuppressive TME
Yufei Wang • 11 Apr 2022
5:26
DFIR CAR T-cell therapy for clear cell RCC
Yufei Wang • 15 Apr 2021
1:11
Impact of the TME on CAR T-cell therapy for kidney cancer
Yufei Wang • 15 Apr 2021

Related Videos

1:33
TranStar101: osemitamab, a novel CLDN18.2 inhibitor, in solid tumors
Yelena Janjigian • 8 Apr 2024
1:33
How can we enhance the efficacy of theranostic nanoparticles?
Debjani Pal • 8 Apr 2024
0:36
The benefits of SJPedPanel, a novel pediatric pan-cancer gene panel
Pandurang Kolekar • 8 Apr 2024
1:08
SJPedPanel: a pan-cancer gene panel for childhood cancers
Pandurang Kolekar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals